LISATA THERAP.INC.DL-001 (8NE) — Net Asset Momentum
LISATA THERAP.INC.DL-001 (8NE) recorded a net asset momentum of -50.2% as of December 2025, with net assets of €14.60 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 8NE net asset value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
LISATA THERAP.INC.DL-001 Net Asset Momentum (2021–2025)
This chart tracks LISATA THERAP.INC.DL-001's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -50.2%, with net assets of €14.60 Million EUR as of December 2025. For live market cap and overall valuation, see LISATA THERAP.INC.DL-001 stock valuation.
Annual Net Asset History for LISATA THERAP.INC.DL-001 (2021–2025)
The table below shows the complete annual net asset history for LISATA THERAP.INC.DL-001 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check LISATA THERAP.INC.DL-001 tangible book value ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €14.60 Million | €17.74 Million | €3.14 Million | ▼ -50.2% |
| 2024 | €29.32 Million | €35.00 Million | €5.68 Million | ▼ -38.8% |
| 2023 | €47.89 Million | €54.69 Million | €6.80 Million | ▼ -27.8% |
| 2022 | €66.32 Million | €73.03 Million | €6.71 Million | ▼ -27.9% |
| 2021 | €92.00 Million | €97.01 Million | €5.01 Million | — |